Inaba S - Search Results

1

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Kong W, et al. Among authors: inaba s. Nat Med. 2004 Dec;10(12):1344-51. doi: 10.1038/nm1135. Epub 2004 Nov 7. Nat Med. 2004. PMID: 15531889 Free article. Clinical Trial.

2

Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.

Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J. Inaba S, et al. Breast Cancer Res Treat. 2005 Nov;94(1):25-35. doi: 10.1007/s10549-005-6938-0. Breast Cancer Res Treat. 2005. PMID: 16142440

3

Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.

Zhou Y, Inaba S, Liu J. Zhou Y, et al. Among authors: inaba s. Int J Oncol. 2006 Jul;29(1):289-95. Int J Oncol. 2006. PMID: 16773211

4

Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.

Gupta A, Inaba S, Wong OK, Fang G, Liu J. Gupta A, et al. Among authors: inaba s. Oncogene. 2003 Oct 23;22(48):7593-9. doi: 10.1038/sj.onc.1206880. Oncogene. 2003. PMID: 14576821

5

Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma.

Fujii M, Inoki I, Saga M, Morikawa N, Arakawa K, Inaba S, Yoshioka K, Konoshita T, Miyamori I. Fujii M, et al. Among authors: inaba s. J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):145-52. doi: 10.1016/j.jsbmb.2011.12.014. Epub 2011 Dec 28. J Steroid Biochem Mol Biol. 2012. PMID: 22212769

6

[Measurement and evaluation of aldosterone].

Inaba S, Miyamori I. Inaba S, et al. Nihon Rinsho. 2005 Mar;63 Suppl 3:245-9. Nihon Rinsho. 2005. PMID: 15813075 Review. Japanese. No abstract available.

7

Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1.

Fan C, Kawai Y, Inaba S, Arakawa K, Katsuyama M, Kajinami K, Yasuda T, Yabe-Nishimura C, Konoshita T, Miyamori I. Fan C, et al. Among authors: inaba s. J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):29-36. doi: 10.1016/j.jsbmb.2008.02.012. Epub 2008 Apr 23. J Steroid Biochem Mol Biol. 2008. PMID: 18514509

8

11beta-hydroxysteroid dehydrogenase in human vascular cells.

Hatakeyama H, Inaba S, Takeda R, Miyamori I. Hatakeyama H, et al. Among authors: inaba s. Kidney Int. 2000 Apr;57(4):1352-7. doi: 10.1046/j.1523-1755.2000.00974.x. Kidney Int. 2000. PMID: 10760066 Free article.

9

[Hypertension due to mutation of mineralocorticoid receptors].

Inaba S, Miyamori I. Inaba S, et al. Nihon Naika Gakkai Zasshi. 2006 Apr 10;95(4):677-82. doi: 10.2169/naika.95.677. Nihon Naika Gakkai Zasshi. 2006. PMID: 16722436 Review. Japanese. No abstract available.

10

A case of Gitelman syndrome associated with idiopathic intracranial hypertension.

Tsutsui H, Hamano T, Kawaura Y, Inaba S, Miyamori I, Yasujima M, Yoneda M, Kuriyama M. Tsutsui H, et al. Among authors: inaba s. Intern Med. 2011;50(14):1493-6. doi: 10.2169/internalmedicine.50.5305. Epub 2011 Jul 15. Intern Med. 2011. PMID: 21757836 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page